Organic Active Ingredients TRIZ Cases

Anti-CD30 antibody conjugated to auristatin targets malignant cells, improving durable remission while reducing patient morbidity.

Modifying substituents on the tetracyclic core improves oral bioavailability and treats resistant cancers.

(Thio)carbamoyl-cyclohexane compounds achieve 5 to 200-fold higher D3 affinity than D2 affinity, reducing extrapyramidal symptoms and cognitive disturbances.

Combining DNA-PK inhibitors with targeted radioimmunotherapy reduces toxicity and treatment frequency by delivering internal radiation doses.

Bicyclic heterocycle compounds target the XIAP BIR3 domain to overcome chemotherapy resistance by sensitizing tumor cells to apoptosis.

Engineered antibody drug conjugates utilize specific linker configurations to stabilize the molecular structure and enhance therapeutic affinity.

Measuring CHI3L1 levels predicts pulmonary fibrosis risk in Hermansky-Pudlak Syndrome, enabling targeted IL-13Rα2 agonist therapy.

In-situ autoclaving combined with controlled ball-milling prevents crystal recrystallization and particle aggregation during sterile suspension manufacturing.

Nylon-3 copolymers replace animal-derived surfactants, eliminating zoonotic infection risks while maintaining high surface activity.

Solutol HS 15 replaces Cremophor to eliminate hypersensitivity reactions while maintaining therapeutic efficacy.

4-Azaindazole compounds inhibit Wnt pathway activity, correcting aberrant growth states and genetic disorders.

A wearable transcutaneous stimulation system uses synchronized ear electrodes to balance autonomic nervous activity.

An insoluble matrix layer maintains core integrity during diffusion-controlled release, simplifying manufacturing by eliminating separate core insertion steps.

An oral dissolvable film uses a polymeric matrix and antioxidants to protect vitamin D3 from degradation, ensuring content uniformity during storage.

Targeting Casein kinase 1 delta normalizes sleep-wake cycles, addressing underlying disruptions in mood disorders.

A dissolution chamber integrated with a urinary catheter system dissolves solid photosensitizing agents directly within the device.

A hydrolysable polymer featuring cationic and hydrophobic side chains transports nucleic acids into cells.

A thickened modified oil-in-water microemulsion solubilizes nonderivatized hormones in an alcohol-modified oil phase for efficient transdermal delivery.

Administers entinostat alongside aromatase inhibitors to reverse tumor resistance and prolong survival while monitoring protein lysine acetylation levels.

Spiropyrazine derivatives target necrosome components to block non-apoptotic cell death in ischemia-reperfusion injury models.

A pentacyclic triterpenoidal saponin derivative with modified C-28 groups.

Fluorinated antihistamine compounds with modified alkyl chains and aromatic rings enhance solubility and stability.

Conjugating perillyl alcohol derivatives with temozolomide overcomes drug resistance and blood-brain barrier limitations in brain metastasis treatment.

Bioxome encapsulation improves topiramate anti-inflammatory efficacy against cellular inflammation and oxidative stress in psoriasis and skin aging.

C5-C6-oxacyclic fused iminopyrimidinone compounds inhibit beta-secretase enzymes, reducing amyloid beta formation to address Alzheimer's disease pathology.

Novel compounds inhibit receptor tyrosine kinases to disrupt tumor growth pathways.

Plant-derived verbascoside extracts replace synthetic filters to provide broad-spectrum UV protection while eliminating adverse skin reactions.

Formula I compounds inhibit proliferation by inducing apoptosis and arresting the cell cycle at the G2/M phase, addressing inadequate therapeutic outcomes.

Chlorogenic acid downregulates MDR1 expression to reverse multidrug resistance in chordoma cells, enabling effective chemotherapy against recurrent tumors.

Adeno-associated viral vectors deliver siRNA molecules to inhibit mutated HTT gene expression, reducing toxic protein production in Huntington's disease.

An IFNAR1 inhibitor blocks interferon signaling to control disease activity while reducing steroid-associated organ damage.

Substituted cyclodextrins act as procoagulants to reverse anticoagulant effects.

Free ropinirole in acrylic adhesive avoids metal salt precipitation and skin irritation.

Pyrazolopyrimidine compounds inhibit the PDE10 enzyme to increase cAMP and cGMP levels, treating schizophrenia with reduced side effects.

Benzofurane derivatives target the farnesoid X receptor to overcome feedback mechanisms that limit cholesterol reduction in existing metabolic therapies.

Tailored biotin formulations address metabolic deficiencies and impaired carboxylase function to improve clinical symptoms.

Gallate compounds solubilize water-insoluble therapeutic agents, enabling effective delivery across biological barriers.

Segmented dual vector delivers co-receptor downregulation and fusion inhibition to overcome HAART side effects and viral drug resistance.

An anti-S100A8 antibody binds S100A8/S100A9 heterodimers to promote leukemia cell differentiation.

Isolated vitamin K formulation administered to animals inhibits methanogenesis pathways, reducing greenhouse gas emissions from livestock.

Benzimidazole compounds inhibit mutated isocitrate dehydrogenase 1 enzyme activity, reducing oncometabolite production in gliomas and leukemias.

Type 2 inhibitors target DFG-out conformation to reduce paradoxical MAPK activation while treating Ras-driven cancers.

Formula I acrylamide compounds inhibit the mitochondrial permeability transition pore while minimizing CYP2D6 inhibition and improving oral bioavailability.

Hyaluronic acid conjugates release nitric oxide upon light exposure.

PVA-PEG graft copolymers absorb high drug loads to prevent film brittleness, ensuring rapid disintegration and homogeneous distribution.

Conjugating anticoagulants to carbon nanocapsules creates targeted carriers that elevate local drug concentration, preventing abnormal bleeding and thrombosis.

A hydroxylated tricyclic compound covalently attached to a water-soluble oligomer via stable linkages.